These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 1647560)

  • 1. Cytomegalovirus infections in the immunocompromised transplant patient. Prevention of cytomegalovirus disease with intravenous immune globulin.
    Snydman DR
    Transplant Proc; 1991 Apr; 23(2 Suppl 1):20-5. PubMed ID: 1647560
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of immune globulin to prevent symptomatic cytomegalovirus disease in transplant recipients--a meta-analysis.
    Glowacki LS; Smaill FM
    Clin Transplant; 1994 Feb; 8(1):10-8. PubMed ID: 8136560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of cytomegalovirus infection in bone marrow transplant recipients by prophylaxis with an intravenous, hyperimmune cytomegalovirus globulin.
    Condie RM; O'Reilly RJ
    Birth Defects Orig Artic Ser; 1984; 20(1):327-44. PubMed ID: 6329370
    [No Abstract]   [Full Text] [Related]  

  • 4. Prevention of cytomegalovirus disease in heart transplant recipients by prophylaxis with cytomegalovirus hyperimmune globulin plus oral acyclovir.
    Eisenmann D; Knipp H; Laube H; Stegmann T
    Transplant Proc; 1990 Oct; 22(5):2322-3. PubMed ID: 2171169
    [No Abstract]   [Full Text] [Related]  

  • 5. Immune globulin therapy in allogeneic bone marrow transplant: a critical review.
    Guglielmo BJ; Wong-Beringer A; Linker CA
    Bone Marrow Transplant; 1994 May; 13(5):499-510. PubMed ID: 8054903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meta-analysis of CMVIG studies for the prevention and treatment of CMV infection in transplant patients.
    Wittes JT; Kelly A; Plante KM
    Transplant Proc; 1996 Dec; 28(6 Suppl 2):17-24. PubMed ID: 9037273
    [No Abstract]   [Full Text] [Related]  

  • 7. A further analysis of primary cytomegalovirus disease prevention in renal transplant recipients with a cytomegalovirus immune globulin: interim comparison of a randomized and an open-label trial.
    Snydman DR; Werner BG; Tilney NL; Kirkman RL; Milford EL; Cho SI; Bush HL; Levey AS; Strom TB; Carpenter CB
    Transplant Proc; 1988 Dec; 20(6 Suppl 8):24-30. PubMed ID: 2849222
    [No Abstract]   [Full Text] [Related]  

  • 8. Intravenous hyperimmune globulin prophylaxis against cytomegalovirus interstitial pneumonitis after allogenic bone marrow transplantation.
    Jacobsen N; Schäfer U; Ostendorf P; Kubaneck B; Wolf H
    Tokai J Exp Clin Med; 1985 Jun; 10(2-3):193-5. PubMed ID: 3010510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Issues concerning the use of intravenous immunoglobulins for the immunoprophylaxis of cytomegalovirus infections in allogeneic bone marrow transplant recipients.
    Emanuel D
    Monogr Allergy; 1988; 23():216-24. PubMed ID: 2838745
    [No Abstract]   [Full Text] [Related]  

  • 10. Prevention of cytomegalovirus disease in transplant recipients.
    Pidgeon GB; Bailey RR
    N Z Med J; 1993 Nov; 106(967):468-9. PubMed ID: 8233192
    [No Abstract]   [Full Text] [Related]  

  • 11. Meta-analysis of immune globulin prophylaxis in transplant recipients for the prevention of symptomatic cytomegalovirus disease.
    Glowacki LS; Smaill FM
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1408-10. PubMed ID: 8382863
    [No Abstract]   [Full Text] [Related]  

  • 12. Immune globulin (GAMMAGARD) prophylaxis of CMV infections in patients undergoing organ transplantation and allogeneic bone marrow transplantation.
    Fehir KM; Decker WA; Samo T; Young JB; Lederer E; Lawrence EC
    Transplant Proc; 1989 Feb; 21(1 Pt 3):3107-9. PubMed ID: 2539691
    [No Abstract]   [Full Text] [Related]  

  • 13. Cytomegalovirus infection in bone marrow transplant recipients: use of intravenous gamma globulin as a prophylactic and therapeutic agent.
    Kapoor N; Copelan EA; Tutschka PJ
    Transplant Proc; 1989 Feb; 21(1 Pt 3):3095-6. PubMed ID: 2539686
    [No Abstract]   [Full Text] [Related]  

  • 14. Use of immune globulin to prevent symptomatic cytomegalovirus disease in transplant recipients--a meta-analysis.
    Snydman DR
    Clin Transplant; 1995 Dec; 9(6):490-1. PubMed ID: 8645893
    [No Abstract]   [Full Text] [Related]  

  • 15. Defining an optimal regimen for cytomegalovirus prophylaxis in organ transplant recipients.
    Paya CV
    Transplant Proc; 1996 Dec; 28(6 Suppl 2):9-11. PubMed ID: 9037269
    [No Abstract]   [Full Text] [Related]  

  • 16. Prophylactic use of immunoglobulin in bone marrow transplantation.
    Ho WG; Winston DJ; Champlin RE; Gale RP
    Int J Cell Cloning; 1986; 4 Suppl 1():174-80. PubMed ID: 3018101
    [No Abstract]   [Full Text] [Related]  

  • 17. [Specific anti-cytomegalovirus immunoglobulins in the prevention of cytomegalovirus infections in bone marrow allografts].
    Huart JJ; Baume D; Jouet JP
    Ann Med Interne (Paris); 1987; 138(5):372-4. PubMed ID: 2823667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CMV-hyperimmune globulin for preventing cytomegalovirus infection and disease in solid organ transplant recipients: a meta-analysis.
    Bonaros N; Mayer B; Schachner T; Laufer G; Kocher A
    Clin Transplant; 2008; 22(1):89-97. PubMed ID: 18217909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytomegalovirus immune globulin for the prevention of primary CMV disease in renal transplant patients: analysis of usage under treatment IND status. The Treatment IND Study Group.
    Werner BG; Snydman DR; Freeman R; Rohrer R; Tilney NL; Kirkman RL
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1441-3. PubMed ID: 8382875
    [No Abstract]   [Full Text] [Related]  

  • 20. Prophylactic application of an anti-cytomegalovirus hyperimmunoglobulin in allogeneic bone marrow transplant recipients.
    Reusser P; Osterwalder B; Gratwohl A; Gratama J; The T; Speck B
    Haematol Blood Transfus; 1987; 30():541-4. PubMed ID: 3040548
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.